NEW YORK (dpa-AFX) – The US stock exchanges rose on the first trading day of the new year. However, profits crumbled completely on Monday and the most important indices briefly plunged into the red. Then they caught up and picked up again. However, the mood of investors across the Atlantic was not quite as positive as that of investors on Europe’s stock exchanges.
Der Dow Jones Industrial was recently friendly with plus 0.09 percent to 36 371.51 points. On the penultimate trading day of 2021, however, the best-known Wall Street index had risen to a record high of just under 36,680 points.
The S&P 500 
, which had also reached a new record last Thursday, now rose by 0.23 percent to 4777.39 points. The tech-heavy Nasdaq 100 gained 0.65 percent to 16425.58 points.
A market observer referred to the more volatile course at the beginning of the year on the one hand on the thin trading turnover. In addition, the US stock exchanges had a very good run in the past year, which is why things should no longer go up so easily. Although the outlook for equities in 2022 is good, monetary policy must now be monitored more closely, he said. Because: The US Federal Reserve announced in December that it would exit its extremely loose monetary policy more quickly in view of the high inflation. The billion dollar purchases of securities such as government bonds are to be scaled back more quickly and interest rates are to be increased again soon. The US central bankers expect a total of three interest rate hikes of 0.25 percentage points each in 2022. “It will be the first rate hike since 2018, and that will have an impact on the stock markets.”
Tesla shares were among the favorites in the US market with a plus of 10 percent, as the electric car manufacturer reported record-high delivery figures. In the fourth quarter, Tesla had delivered over 300,000 vehicles to customers, far more than had been expected on the market. In the entire year 2021, the company will deliver a good 936,000 deliveries, an increase of 87 percent compared to 2020.
In the Dow, shares of Boeing were front runner up 4.4 percent, followed by the bank stocks JPMorgan and Goldman Sachs, which rose 2.4 and 3.3 percent respectively. The paper from the sporting goods manufacturer Nike, on the other hand, was one of the weakest values with minus 1.7 percent.
Moderna held the red lantern on the Nasdaq 100 with minus 6.9 percent. Biontech fell 5.5 percent on the Nasdaq. Pfizer’s drug Paxlovid against Covid-19 is about to be approved in Germany. The US Food and Drug Administration (FDA) issued an emergency approval for paxlovid shortly before Christmas.
– .
